ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 13 of 45
JMBS 2018, 3(4): 73–77
Clinical Medicine

Peculiarities of Asthma and Insulin Resistance Depending on the Types of Obesity

Yeryomenko G.

The purpose of the study was to examine specific clinical and laboratory signs and peculiarities of fatty tissue distribution in patients with bronchial asthma associated with diabetes mellitus, and their effect on respiration function (RF). Material and methods. 78 patients with non-controlled severe-course asthma and diabetes mellitus type 2 were studied. The patients were divided into 2 groups, with android and gynoid obesity types, according to anthropometric signs. Blood chemistry panel was performed: glycated hemoglobin (HbAlc), glucose, triglycerides (TG), total cholesterol (CHOL), low density lipoproteins (LDL), high density lipoproteins (HDL), and insulin resistance index (HOMA-IR). Concentrations of total CHOL, TG, high density lipoproteins (HDL), and low density lipoproteins (LDL) were determined using enzymatic method via photometer Solar PM 2111. Expiratory reserve flow (ERF), forced vital capacity (FVC) and forced expiratory volume for 1st second (FEV1) condition was evaluated based on analysis on a spirograph Spìrokom (Ukraine). Besides, the control level of asthma symptoms was considered using questionnaires ACQ-5. Results and discussion. The android type patients were older and had longer disease history versus the patients with gynoid obesity type. The increase of abdominal fat depots in patients with android type obesity was associated with more pronounced changes in carbohydrate-fat metabolism parameters, which was manifested through elevated glucose, TG, LDL serum values and decreased HDL concentrations. HbAlc and HOMA-IR were reliably increased. Assessment of external respiration function via a spirometer showed that FEV1 %, FVC % in patient groups with gynoid and android obesity types were different as well. In patients with android obesity type, FEV1 and FVC parameters were reliably lower than in the group with gynoid obesity type. Higher degree of ventilation disorders in individuals with high waist circumference – thigh circumference index can be due to fatty tissue central topography type. Conclusions. The obtained data are indicative of various carbohydrate metabolism disorders, dependence of insulin resistance on obesity type, hormonal balance, and RF decrease. Nevertheless, further complex studies, aimed at investigation of clinical peculiarities and hormonal support of pathological processes in patients with the examined pathology are required.

Keywords: bronchial asthma, diabetes mellitus type 2, obesity

Full text: PDF (Eng) 176K

  1. Fomina DS, Goryachkina LA, Alekseeva YuG, i dr. Bronkhialnaya astma i ozhirenie: poisk terapevticheskikh modeley. Pulmonologiya. 2014; 6: 94-100. [Russian]
  2. Butrova SA, Dzgoeva FKh. Vistseralnoe ozhirenie – klyuchevoe zveno metabolicheskogo sindroma. Ozhirenie i metabolizm. 2004; 1: 10-3. [Russian]
  3. Butrova CA. Sindrom insulinorezistentnosti pri abdominalnom ozhirenii. Lechashchiy Vrach. 1999; 7: 6–10. [Russian]
  4. Ivanov VA, Sorokina LI, Mineev VN. Sochetanie bronkhialnoy astmy i sakharnogo diabeta: sinergizm ili antagonizm? Pulmonologiya. 2014; 6: 103-7. [Russian]
  5. Kamaev IA, Kabanova SL. Osobennosti kachestva zhizni bolnykh sakharnym diabetom 2 tipa, prozhivayushchikh v selskoy mestnosti. Arkhiv vnutrenney meditsiny. 2012; 2 (4): 68-70. [Russian]
  6. Melnichenko GA. Ozhirenie i insulinorezistentnost faktory riska i sostavnaya chast metabolicheskogo sindroma. Terapevticheskiy arkhiv. 2001; 73 (12): 5-8. [Russian]
  7. Al-Daghri NM, Al-Attas OS, Bindahman LS, Alokail MS, Alkharfy KM, Draz HM, Yakout S, [et al.] Soluble CD163 is associated with bodymass index and blood pressure in hypertensive obese Saudi patients. Eur J Clin Invest. 2012; 42: 1221-6.
  8. Al-Shawwa BA, Al-Huniti NH, DeMattia L, Gershan W. Insulin resistance in morbidly obese children and adolescents. Asthma. 2007; 44: 469-73.
  9. Brenner JS, Kelly CS, Wenger AD, Brich SM, Morrow AL. Asthma and obesity in adolescents: is there an association? Asthma. 2001; 38 (6): 509-15.
  10. Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the Recognise Asthma and Link to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014; 24:14009.
  11. Boulet LP. Asthma and obesity. Clin Exp Allergy. 2013; 43 (1): 8-21.
  12. Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, Ernst ND, Horan M. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res. 2000; 8: 605–19.
  13. Dixon AE, Poynter ME. Mechanisms of asthma in obesity. pleiotropic aspects of obesity produce distinct asthma phenotypes. Am J Respir Cell and Molec Biology. 2016; 54 (5): 601-8.
  14. Ehrlich SF, Quesenberry CP Jr, Van Den Eeden SK, Shan J, Ferrara A. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes care. 2010; 33: 55-60.
  15. Mohammadreza B, Farzad H, Davoud K, Fereidoun Prof AF. Prognostic significance of the Complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study. Cardiovasc Diabetol. 2012; 11: 20.
  16. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008; 358: 580-91.
  17. Geetha L, Deepa M, Anjana RM, Mohan V. Prevalence and Clinical Profile of Metabolic Obesity and Phenotypic Obesity in Asian Indians. J Diab Sci Technol. 2011; 5 (2): 439–46.
  18. Chen YC, Dong GH, Lin KC, Lee YL. Gender difference of childhood overweight and obesity in predicting the risk of incident asthma: a systematic review and meta-analysis. Obes Rev. 2013; 14; 3: 222-31.
  19. FitzGerald JM, Bateman ED, Boulet L-Ph, et al. Global Strategy for Asthma Management and Prevention (2015 update) [Digital resource]. Available from:
  20. Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, Charlson F, et al. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015; 386: 743-800.
  21. Hashemzadeh M, Movahed MR. The occurrence of asthma in hospitalized patients with type 2 diabetes mellitus. Intern Med J. 2009; 39 (10): 699-701.
  22. Litonjua AA, Lazarus R, Sparrow D, Demolles D, Weiss ST. Lung function in type 2 diabetes: the Normative Aging Study. Respir Med. 2005; 99 (12): 1583–90.
  23. Muc M, Mota-Pinto A, Padez C. Association between obesity and asthma – epidemiology, pathophysiology and clinical profile. Nutr Res Rev. 2016; 12: 1-8.
  24. Poulain M, Doucet M, Major GC, Drapeau V, Sériès F, Boulet LP, Tremblay A, Maltais F. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ. 2006; 174 (9): 1293-9.
  25. WHO. Prevention and management of the global epidemic of obesity. Report of the WHO consultation on obesity. Geneva; 1997
  26. Yao TC, Ou LS, Yeh KW, Lee WI, Chen LC, Huang JL; PATCH Study Group. Associations of age, gender, and BMI with prevalence of allergic diseases in children: PATCH study. J Asthma. 2011; 48: 503-10.
  27. Yuksel H, Sogut A, Yilmaz O, Onur E, Dinc G. Role of Adipokines and Hormones of Obesity in Childhood Asthma. Allergy Asthma Immunol Res. 2012; 4: 98-103.